Skip to main content
Caplight Logo









Diagnóstica Longwood

Diagnóstica Longwood

Private
ZaragozaHealthcare & Life Scienceshttps://www.dlongwood.com/

Last Round

Private Equity

Jul 16, 2025

Total Funding Raised

$544,000

Company Overview

Diagnóstica Longwood is a healthcare company that provides advanced in-vitro diagnostic equipment, molecular biology solutions, and technical support services for clinical and research laboratories.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Precision Medicine, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

in-vitro diagnosticsIVDnext-generation sequencingNGSmolecular diagnosticsgenomic analysislaboratory equipment distributorclinical diagnosticsprecision medicinelab automationdiagnostic reagentsbiotech supplyclinical interpretation softwarelab workflow optimizationgenetics lab services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Diagnóstica Longwood Comparables

Compare Diagnóstica Longwood with similar companies based on industry and business-model similarity.

Diagnóstica Longwood comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vitro Group
86%
Labclinics
83%
Quilaban
82%

Diagnóstica Longwood Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityJul 16, 2025
GrantJan 27, 2023

Key People

Founding team and executive leadership

Miguel Giralt

Chief Executive Officer

Executive Team

Juan Rodríguez

Chief Financial Officer

Executive Team

Diagnóstica Longwood Investors

Notable investors and investment history

Diagnóstica Longwood investors
InvestorRounds
ApheonPrivate Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 3, 2026

    Monthly visitors increased 43% MoM, reaching 7.4K.

  • Feb 1, 2026

    Grew 32% QoQ, from 71 to 94 employees.

Diagnóstica Longwood Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Diagnóstica Longwood Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Diagnóstica Longwood's valuation, stock price, and market status.

Firmographic Details

HeadquartersZaragoza
Employee Range104
Year Founded1992
Last FundingJul 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?